Advanced therapies: research and development

  • Email
  • Help

The European Medicines Agency (EMA) provides guidance and support to companies researching, developing and manufacturing advanced therapy medicinal products (ATMPs). This includes scientific and regulatory guidance, compliance standards as well as incentives for companies developing ATMPs.

In this section

 

Action plan to foster development of ATMPs (new)

In October 2017, the European Commission and EMA published a joint action plan to foster the development of ATMPs:

It contains several actions for the European Commission and EMA.

The action plan takes into account the ideas collected at an EMA-hosted multi-stakeholder workshop to explore solutions to challenges in the development of ATMPs.

How helpful is this page?

Average rating:

 Based on 8 ratings

Add your rating:

See all ratings
3 ratings
1 ratings
2 ratings
0 ratings
2 ratings
    

Tell us more

Related content

External links

Contact point

advancedtherapies@ema.europa.eu